The trajectory of Sildenafil presents a challenging picture for shareholders. While the initial launch generated significant gains, the end of its intellectual property protection opened the avenue to generic versions, https://mediasocially.com/story6612250/viagra-and-the-pharmaceutical-industry-a-precarious-investment